DK1628663T3 - Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose - Google Patents
Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikroglioseInfo
- Publication number
- DK1628663T3 DK1628663T3 DK04752432.7T DK04752432T DK1628663T3 DK 1628663 T3 DK1628663 T3 DK 1628663T3 DK 04752432 T DK04752432 T DK 04752432T DK 1628663 T3 DK1628663 T3 DK 1628663T3
- Authority
- DK
- Denmark
- Prior art keywords
- amyloid
- microgliosis
- reducing
- animals
- neurotoxicity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47069403P | 2003-05-15 | 2003-05-15 | |
PCT/US2004/015417 WO2004110354A2 (en) | 2003-05-15 | 2004-05-17 | Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1628663T3 true DK1628663T3 (da) | 2010-03-08 |
Family
ID=33551420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04752432.7T DK1628663T3 (da) | 2003-05-15 | 2004-05-17 | Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose |
Country Status (10)
Country | Link |
---|---|
US (1) | US7732467B2 (da) |
EP (1) | EP1628663B1 (da) |
JP (1) | JP4971794B2 (da) |
CN (1) | CN100444840C (da) |
AT (1) | ATE437641T1 (da) |
CA (1) | CA2525970C (da) |
DE (1) | DE602004022284D1 (da) |
DK (1) | DK1628663T3 (da) |
ES (1) | ES2334029T3 (da) |
WO (1) | WO2004110354A2 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1858325A4 (en) * | 2005-01-07 | 2010-06-30 | Roskamp Res Llc | COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION AND METHODS FOR IDENTIFYING THESE COMPOUNDS |
ES2374716T3 (es) * | 2005-04-15 | 2012-02-21 | Research & Innovation S.P.A. | Método para prevenir, retrasar o revertir la deposición anormal de amiloide. |
JP2009528380A (ja) * | 2006-03-01 | 2009-08-06 | ロスキャンプ リサーチ, エルエルシー | βアミロイドの生成を抑制する化合物 |
US20100119599A1 (en) * | 2006-12-08 | 2010-05-13 | Archer Pharmaceuticals, Inc. | Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production |
US8709394B2 (en) * | 2007-09-28 | 2014-04-29 | Ndsu Research Foundation | Antimicrobial polysiloxane materials containing metal species |
WO2009046338A1 (en) * | 2007-10-05 | 2009-04-09 | Roskamp Research Llc | Method for increasing cerebral blood flow with (+)-nilvadipine enantiomer |
US20100093810A1 (en) * | 2007-10-05 | 2010-04-15 | Alzheimer's Institute Of America, Inc. | Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis |
AU2008308519B2 (en) * | 2007-10-05 | 2014-09-11 | Alzheimer's Institute Of America, Inc. | Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer |
MX2011012015A (es) * | 2009-05-15 | 2012-04-30 | Univ Kentucky Res Found | Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer. |
EP2311823A1 (en) * | 2009-10-15 | 2011-04-20 | AC Immune S.A. | 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
KR20140128229A (ko) * | 2013-04-26 | 2014-11-05 | 한국과학기술연구원 | 체내 단백질 응집체의 용해를 이용한 단백질의 비정상적인 응집 또는 미스폴딩과 관련된 질환 또는 질병을 진단하는 혈액진단키트 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338322A (en) * | 1975-07-02 | 1982-07-06 | Fujisawa Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same |
JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
JPS61129140A (ja) | 1984-11-27 | 1986-06-17 | Nitto Electric Ind Co Ltd | 医薬組成物 |
GB8431119D0 (en) * | 1984-12-10 | 1985-01-16 | Fujisawa Pharmaceutical Co | Anti-arteriosclerotic composition |
US4940556A (en) | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
US5001139A (en) * | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
US4992445A (en) * | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US5114946A (en) * | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
EP0294601B1 (en) | 1987-06-12 | 1993-01-20 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
US4820720A (en) * | 1987-08-24 | 1989-04-11 | Alza Corporation | Transdermal drug composition with dual permeation enhancers |
US5160734A (en) * | 1987-11-25 | 1992-11-03 | American Cyanamid Company | Sustained release delivery system for substituted dihydropyridine calcium channel blockers |
DE3871343D1 (de) | 1987-11-25 | 1992-06-25 | American Cyanamid Co | System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridin-calciumantagonisten. |
US4902514A (en) * | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
DE69027026T2 (de) * | 1989-03-31 | 1996-09-26 | Childrens Medical Center | Behandlung von aids, dementia, myelopathie und blindheit |
JP2867462B2 (ja) | 1989-09-12 | 1999-03-08 | 藤沢薬品工業株式会社 | 経皮吸収用製剤 |
JPH03117658A (ja) | 1989-09-29 | 1991-05-20 | Mazda Motor Corp | 外燃式ロータリピストンエンジン |
JP2920956B2 (ja) | 1989-10-06 | 1999-07-19 | 藤沢薬品工業株式会社 | ニルバジピン含有持続性錠剤 |
EP0557290A1 (en) | 1990-08-23 | 1993-09-01 | The Children's Medical Center Corporation | Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
WO1993005770A1 (en) | 1991-09-20 | 1993-04-01 | Fujisawa Pharmaceutical Co., Ltd. | Long-acting preparation |
JPH05139974A (ja) | 1991-11-26 | 1993-06-08 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固体分散体の製造法 |
DE4141646A1 (de) | 1991-12-17 | 1993-06-24 | Klinge Co Chem Pharm Fab | Arzneimittelkombination mit synergistischer wirkung, verfahren zu seiner herstellung und seine verwendung |
US5340591A (en) * | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
DE4229805A1 (de) * | 1992-09-07 | 1994-03-24 | Werner E G Prof Dr Mueller | Kalzium-Kanal-Antagonisten oder deren Derivate zur Herstellung eines Arzneimittels zur Bekämpfung von Erkrankungen, die durch Prion-Proteine oder Prion-analoge Proteine ausgelöst werden |
US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
CA2125251C (en) | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
US6334997B1 (en) * | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
CN1216469A (zh) * | 1996-04-26 | 1999-05-12 | 藤泽药品工业株式会社 | 含有二氢吡啶类化合物的眼组织末梢循环改善剂 |
US6271259B1 (en) * | 1996-05-07 | 2001-08-07 | Ito En, Ltd. | Method for improving the brain function, inhibiting glutamate excitotoxicity and rescuing from neuronal death |
KR100222306B1 (ko) | 1996-11-20 | 1999-10-01 | 이병언 | 닐바디핀 속효성 고형제제 및 이의 제조방법 |
AU4549399A (en) | 1998-06-08 | 1999-12-30 | Theravance, Inc. | Novel calcium channel drugs and uses |
WO1999063932A2 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding agents that modulate the 5-ht transporter |
SI1096932T1 (sl) | 1998-07-10 | 2008-04-30 | Novartis Pharma Ag | Antihipertenzivna kombinacija valsartana in zaviralca kalcijevih kanalov |
EP1260232A1 (en) | 2000-03-03 | 2002-11-27 | Fujisawa Pharmaceutical Co., Ltd. | Remedies for malignant tumor-concomitant neurosis and azoor or analogous diseases thereof |
ATE363281T1 (de) | 2000-04-11 | 2007-06-15 | Sankyo Co | Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten |
JP2001335483A (ja) | 2000-05-30 | 2001-12-04 | Nichiko Pharmaceutical Co Ltd | ニルバジピン含有製剤 |
AU2001278045B2 (en) * | 2000-07-27 | 2006-08-03 | Pharmacia Corporation | Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
JP3968687B2 (ja) | 2000-09-13 | 2007-08-29 | 東和薬品株式会社 | 易吸収性ニルバジピン錠 |
JP3470096B2 (ja) | 2000-09-19 | 2003-11-25 | 沢井製薬株式会社 | ニルバジピン含有易溶性固形製剤およびその製造法 |
MXPA03005393A (es) * | 2000-12-19 | 2003-09-25 | Merck Patent Gmbh | Formulacion farmaceutica que contiene pirazolo (4,3-d) pirimidinas y antitromboticos, antagonistas de calcio, prostaglandinas o derivados de prostaglandina. |
AU2002227957A1 (en) * | 2000-12-19 | 2002-07-01 | Merck Patent Gmbh | Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
US7083642B2 (en) * | 2000-12-22 | 2006-08-01 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
CA2333494A1 (en) * | 2001-02-01 | 2002-08-01 | Vasogen Ireland Limited | Blood brain barrier modulation |
CA2447884A1 (en) | 2001-05-25 | 2002-12-05 | Schering Corporation | Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
PE20040468A1 (es) | 2002-05-17 | 2004-09-14 | Novartis Ag | Combinacion de compuestos organicos |
AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
EG24716A (en) | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
US20050182042A1 (en) | 2002-05-17 | 2005-08-18 | Feldman David L. | Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
JP2003146878A (ja) | 2002-11-22 | 2003-05-21 | Sawai Pharmaceutical Co Ltd | ニルバジピン含有易溶性固形製剤およびその製造法 |
US20050031651A1 (en) * | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
NZ541282A (en) | 2002-12-24 | 2009-02-28 | Bellus Health International Ltd | Therapeutic formulations for the treatment of beta-amyloid related diseases |
JP2004002460A (ja) | 2003-07-29 | 2004-01-08 | Towa Yakuhin Kk | 易吸収性ニルバジピン錠の製造法 |
-
2004
- 2004-05-17 CN CNB2004800171974A patent/CN100444840C/zh not_active Expired - Fee Related
- 2004-05-17 DE DE602004022284T patent/DE602004022284D1/de not_active Expired - Lifetime
- 2004-05-17 WO PCT/US2004/015417 patent/WO2004110354A2/en active Search and Examination
- 2004-05-17 AT AT04752432T patent/ATE437641T1/de not_active IP Right Cessation
- 2004-05-17 EP EP04752432A patent/EP1628663B1/en not_active Expired - Lifetime
- 2004-05-17 DK DK04752432.7T patent/DK1628663T3/da active
- 2004-05-17 ES ES04752432T patent/ES2334029T3/es not_active Expired - Lifetime
- 2004-05-17 JP JP2006533144A patent/JP4971794B2/ja not_active Expired - Lifetime
- 2004-05-17 CA CA2525970A patent/CA2525970C/en not_active Expired - Fee Related
- 2004-05-17 US US10/847,630 patent/US7732467B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2004110354A2 (en) | 2004-12-23 |
HK1092358A1 (en) | 2007-02-09 |
CA2525970C (en) | 2011-03-22 |
CN100444840C (zh) | 2008-12-24 |
JP4971794B2 (ja) | 2012-07-11 |
ATE437641T1 (de) | 2009-08-15 |
JP2007501277A (ja) | 2007-01-25 |
CN1809352A (zh) | 2006-07-26 |
US20050009885A1 (en) | 2005-01-13 |
WO2004110354A3 (en) | 2005-02-10 |
ES2334029T3 (es) | 2010-03-04 |
EP1628663A4 (en) | 2006-05-24 |
US7732467B2 (en) | 2010-06-08 |
EP1628663A2 (en) | 2006-03-01 |
DE602004022284D1 (de) | 2009-09-10 |
EP1628663B1 (en) | 2009-07-29 |
CA2525970A1 (en) | 2004-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
ATE492279T1 (de) | Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen | |
PH12021553223A1 (en) | IMIDAZO[1,2-a]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | |
NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
BRPI0712322A2 (pt) | compostos e combinações destes para a inibição da produção de beta-amilóide e métodos de uso dos mesmos | |
CY1108514T1 (el) | Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων | |
ECSP055719A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
WO2001009118A3 (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
ATE451368T1 (de) | Azabicyclische verbindungen zur linderung von schmerzen und zur behandlung von erkrankungen des zentralen nervensystems | |
DE60134453D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten | |
DE60324449D1 (de) | Inhibitoren der phosphodiesterase der zyklischen n, und deren verwendung in therapie | |
PH12021553232A1 (en) | 2h-indazole derivatives and their use in the treatment of disease | |
ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
DK1628663T3 (da) | Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose | |
BR0306855A (pt) | Método para o tratamento de distúrbios cognitivos | |
IL176453A0 (en) | Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases | |
WO2005046605A3 (en) | Compositions and methods of treating neurological diseases | |
ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
TW200510351A (en) | Oxazole compounds for the treatment of neurodegenerative disorders | |
ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
ATE448779T1 (de) | Methode zur behandlung trockener augen und uveitis | |
US8182844B2 (en) | Use of Clerodendrum sp. for treating tic disorders or psychiatric disorders with sensorimotor gating deficits | |
WO2020061257A3 (en) | Biological bits as computable elements within living systems |